The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.

doi:10.21873/anticanres.12643

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.

Anticancer research - 1 Jun 2018

Jurečeková Jana, Drobková Henrieta, Šarlinová Miroslava, Babušíková Eva, Sivoňová Monika Kmeťová, Matáková Tatiana, Kliment Ján, Halašová Erika

Abstract excerpt

BACKGROUND/AIM: Interleukin-6 is an important modulator of inflammation, which is one of the factors involved in prostate cancer. The aim of the study was to evaluate the possible association of the IL-6 -174 polymorphism (rs1800795) with the risk of prostate cancer development and progression. MATERIALS AND METHODS: The study population consisted of 446 prostate cancer patients, 377 benign prostatic hyperplasia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles

Share to Disease Progression

Share to Gene Frequency

Share to Interleukin-6

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 29848725
DOI: 10.21873/anticanres.12643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.PMID 29848725Read ↗

An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian PopulationSemantic proximity Read ↗

Role of interleukin-6 gene polymorphisms in the development of prostate cancer.Semantic proximity Read ↗

Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Semantic proximity Read ↗

Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.Semantic proximity Read ↗

The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia.Semantic proximity Read ↗

Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.Semantic proximity Read ↗

-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Semantic proximity Read ↗

Association between interleukin-18 variants and prostate cancer in Slovak population.Semantic proximity Read ↗

Association between -174 G/C promoter polymorphism of the interleukin-6 gene and progression of prostate cancer in North Indian population.Semantic proximity Read ↗

Association of interleukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population.Semantic proximity Read ↗

Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.